Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Elusys_Therapeutics> ?p ?o }
Showing triples 1 to 59 of
59
with 100 triples per page.
- Elusys_Therapeutics abstract "Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side. The pathogens will be dragged to the liver where they will be destroyed. The antibodies have a potential to be used for the treatments of many blood-borne diseases. Currently, the company focuses on the late-stage clinical trials of Anthim (Obiltoxaximab) to used for treatment and prevention of inhaled anthrax.".
- Elusys_Therapeutics type Privately_held_company.
- Elusys_Therapeutics wikiPageID "48670320".
- Elusys_Therapeutics wikiPageLength "6583".
- Elusys_Therapeutics wikiPageOutDegree "30".
- Elusys_Therapeutics wikiPageRevisionID "692803912".
- Elusys_Therapeutics wikiPageWikiLink Anthrax.
- Elusys_Therapeutics wikiPageWikiLink Bacillus_anthracis.
- Elusys_Therapeutics wikiPageWikiLink Biologic_license_application.
- Elusys_Therapeutics wikiPageWikiLink Biopharmaceutical.
- Elusys_Therapeutics wikiPageWikiLink Bioterrorism.
- Elusys_Therapeutics wikiPageWikiLink Board_of_directors.
- Elusys_Therapeutics wikiPageWikiLink Category:Companies_based_in_Morris_County,_New_Jersey.
- Elusys_Therapeutics wikiPageWikiLink Category:Pharmaceutical_companies_based_in_New_Jersey.
- Elusys_Therapeutics wikiPageWikiLink DARPA.
- Elusys_Therapeutics wikiPageWikiLink Food_and_Drug_Administration.
- Elusys_Therapeutics wikiPageWikiLink Hoffmann-La_Roche.
- Elusys_Therapeutics wikiPageWikiLink Infection.
- Elusys_Therapeutics wikiPageWikiLink Intramuscular_injection.
- Elusys_Therapeutics wikiPageWikiLink Intravenous_therapy.
- Elusys_Therapeutics wikiPageWikiLink Monoclonal_antibody.
- Elusys_Therapeutics wikiPageWikiLink National_Institutes_of_Health.
- Elusys_Therapeutics wikiPageWikiLink Obiltoxaximab.
- Elusys_Therapeutics wikiPageWikiLink Pathogen.
- Elusys_Therapeutics wikiPageWikiLink Pine_Brook,_Morris_County,_New_Jersey.
- Elusys_Therapeutics wikiPageWikiLink Privately_held_company.
- Elusys_Therapeutics wikiPageWikiLink Strategic_National_Stockpile.
- Elusys_Therapeutics wikiPageWikiLink Systemic_lupus_erythematosus.
- Elusys_Therapeutics wikiPageWikiLink United_States_Army_Medical_Research_Institute_of_Infectious_Diseases.
- Elusys_Therapeutics wikiPageWikiLink United_States_Department_of_Health_and_Human_Services.
- Elusys_Therapeutics wikiPageWikiLink University_of_Texas_at_Austin.
- Elusys_Therapeutics wikiPageWikiLink University_of_Virginia.
- Elusys_Therapeutics wikiPageWikiLink Venture_capital.
- Elusys_Therapeutics wikiPageWikiLinkText "Elusys Therapeutics".
- Elusys_Therapeutics founded "1998".
- Elusys_Therapeutics hqLocation Pine_Brook,_Morris_County,_New_Jersey.
- Elusys_Therapeutics keyPeople "Dr. Elizabeth G. Posillico".
- Elusys_Therapeutics name "Elusys Therapeutics".
- Elusys_Therapeutics type Privately_held_company.
- Elusys_Therapeutics wikiPageUsesTemplate Template:Infobox_company.
- Elusys_Therapeutics wikiPageUsesTemplate Template:Reflist.
- Elusys_Therapeutics subject Category:Companies_based_in_Morris_County,_New_Jersey.
- Elusys_Therapeutics subject Category:Pharmaceutical_companies_based_in_New_Jersey.
- Elusys_Therapeutics hypernym Company.
- Elusys_Therapeutics type Agent.
- Elusys_Therapeutics type Company.
- Elusys_Therapeutics type Organisation.
- Elusys_Therapeutics type Organization.
- Elusys_Therapeutics type Agent.
- Elusys_Therapeutics type SocialPerson.
- Elusys_Therapeutics type Thing.
- Elusys_Therapeutics type Q43229.
- Elusys_Therapeutics comment "Elusys Therapeutics is a biopharmaceutical company founded in Pine Brook, New Jersey in 1998. The company specializes in the development of antibodies for the treatment infectious diseases. The antibodies are developed from protein complexes called heteropolymers which can bind to specific pathogens on one side and red blood cells on the other side. The pathogens will be dragged to the liver where they will be destroyed.".
- Elusys_Therapeutics label "Elusys Therapeutics".
- Elusys_Therapeutics sameAs Q22079523.
- Elusys_Therapeutics sameAs Q22079523.
- Elusys_Therapeutics wasDerivedFrom Elusys_Therapeutics?oldid=692803912.
- Elusys_Therapeutics isPrimaryTopicOf Elusys_Therapeutics.
- Elusys_Therapeutics name "Elusys Therapeutics".